Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.7K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

360
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

432
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

469
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
469
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

538
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
538

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors and Consequences of Serious Adverse Events in Patients Treated With Thrombolysis: A Prespecified Secondary Analysis of the AcT Trial.

Journal of the American Heart Association·2026
Same author

Effect of time on reperfusion in acute ischemic stroke treated with thrombolysis within the 4.5-hour window: a secondary analysis of the AcT Trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Tenecteplase versus alteplase in elderly stroke: a post hoc analysis of the AcT trial.

Stroke and vascular neurology·2026
Same author

Effects of Fibrinogen on Tenecteplase Treatment in Acute Ischaemic Stroke After 4.5 Hours of Symptom Onset: A Post Hoc Analysis of the TRACE-III Trial.

Neurology and therapy·2026
Same author

Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial.

JAMA·2026
Same author

AcT Trial: Protocol for a Pragmatic Registry-Linked Randomized Clinical Trial.

Stroke (Hoboken, N.J.)·2026
Same journal

Editors and Editorial Board.

Circulation research·2026
Same journal

Cannabis Is Associated With Potentially Proatherogenic Inflammation in Youth.

Circulation research·2026
Same journal

WTAP Deficiency Promotes Podocyte PANoptosis and FSGS via SPP1 Signaling.

Circulation research·2026
Same journal

B1a Cell-IgM Axis Protects Against Hypertension by Blunting IFNγ+CD4+T Cells.

Circulation research·2026
Same journal

SBK2 Links Cardiac Stress Signaling to Mitochondrial Proteostasis.

Circulation research·2026
Same journal

Myeloid Piezo1 as a Brake on Efferocytosis and Cardiac Repair in the Infarcted Heart.

Circulation research·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Acute Ischemic Stroke Therapy Overview.

Luciana Catanese1, Joseph Tarsia1, Marc Fisher2

  • 1From the Department of Neurology, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA.

Circulation Research
|February 4, 2017
PubMed
Summary
This summary is machine-generated.

Recent advancements in acute ischemic stroke treatment include intra-arterial (IA) therapies and advanced imaging. These improve patient selection and expand treatment windows for large-vessel occlusions, marking a new era in stroke care.

Keywords:
imaginginterventionstroketherapythrombolysis

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.6K

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Emergency Medicine

Background:

  • Acute ischemic stroke treatment has evolved significantly with new device-based therapies.
  • Timely imaging (CT/MRI) is crucial for selecting patients for intravenous and intra-arterial (IA) interventions.
  • Large-vessel occlusions are key targets for advanced stroke interventions.

Purpose of the Study:

  • To review recent changes and advancements in acute ischemic stroke treatment.
  • To highlight the role of imaging in patient selection for IA therapy.
  • To discuss the potential of novel treatment paradigms and regional stroke systems.

Main Methods:

  • Review of recent clinical trials demonstrating efficacy of IA device-based therapy.
  • Analysis of imaging modalities (CT, MRI, angiography) for diagnosing large-vessel occlusions.
  • Discussion of current treatment guidelines and future therapeutic directions.

Main Results:

  • Intra-arterial (IA) device-based therapy has shown demonstrated efficacy in multiple trials.
  • Advanced imaging can identify ischemic core and penumbra, aiding treatment decisions.
  • Intravenous thrombolysis remains standard within 4.5 hours; IA therapy is effective for large-vessel occlusions within 6 hours.

Conclusions:

  • Acute ischemic stroke treatment is rapidly advancing, entering a 'golden age'.
  • Optimized patient selection using advanced imaging and expanded time windows are critical.
  • Regional stroke systems and novel therapies like neuroprotection combined with IA treatment hold future promise.